K. Syndulko

发表

Development of a multiple sclerosis functional composite as a clinical trial outcome measure.

Stephen M. Rao, S. Reingold, A. Thompson, 1999, Brain : a journal of neurology.

Electrocortical signs of levels of processing: perceptual analysis and recognition memory.

J. Rohrbaugh, D. Lindsley, T. Sanquist, 1980, Psychophysiology.

Use of P300 and a dementia rating scale in the evaluation of cognitive dysfunction in MS

Karl Syndulko, K. Syndulko, W. Tourtellotte, 1984, Acta neurologica Scandinavica. Supplementum.

Human Neurologic Function and the Aging Process †

K. Syndulko, A. Potvin, W. Tourtellotte, 1980, Journal of the American Geriatrics Society.

Bromocriptine in the treatment of alcoholics with the D2 dopamine receptor A1 allele

R. Young, K. Syndulko, E. Noble, 1995, Nature Medicine.

Palinopsia reconsidered

J. Cummings, D. Treiman, K. Syndulko, 1982, Neurology.

Computer Based Memory Training and Memory Prosthesis in Older Adults

K. Syndulko, W. Tourtellotte, V. Crooks, 1984 .

Preliminary Evaluation of Lowering Tympanic Temperature for the Symptomatic Treatment of Multiple Sclerosis

K. Syndulko, W. Tourtellotte, R. Baumhefner, 1995 .

Multiple sclerosis de novo CNS IgG synthesis

K. Syndulko, W. Tourtellotte, M. Mendez, 1980, Neurology.

Parkinson's disease: Cogentin with Sinemet, a better response.

K. Syndulko, W. Tourtellotte, A. Potvin, 1982, Progress in neuro-psychopharmacology & biological psychiatry.

Parkinson's disease: Cogentinr with sinemetr, a better response

K. Syndulko, W. Tourtellotte, A. Potvin, 1982, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

Increased ratio of carbidopa to levodopa in treatment of Parkinson's disease.

K. Syndulko, W. Tourtellotte, A. Potvin, 1980, Archives of neurology.

Aversive conditioning in the sociopath

K. Syndulko, I. Maltzman, E. Ziskind, 1978, The Pavlovian journal of biological science.

Quantifying HIV-1 RNA using the polymerase chain reaction on cerebrospinal fluid and serum of seropositive individuals with and without neurologic abnormalities.

E. Singer, K. Syndulko, W. Tourtellotte, 1995, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.

Search for virus nucleic acid sequences in postmortem human brain tissue using in situ hybridization technology with cloned probes: Some solutions and results on progressive multifocal leukoencephalopathy and subacute sclerosing panencephalitis tissue

M. Wolman, K. Syndulko, W. Tourtellotte, 1986, Journal of neuroscience research.

Multimodality evoked potentials and neurophysiological tests in multiple sclerosis. Effects of hyperthermia on test results.

K. Syndulko, W. Tourtellotte, A. Potvin, 1983, Archives of neurology.

Multiple sclerosis de novo CNS IgG synthesis. Effect of CNS irradiation.

Z. Petrovich, K. Syndulko, W. Tourtellotte, 1980, Archives of neurology.

Quantitative multiple sclerosis plaque assessment with magnetic resonance imaging. Its correlation with clinical parameters, evoked potentials, and intra-blood-brain barrier IgG synthesis.

K. Syndulko, G. Ellison, W. Tourtellotte, 1990, Archives of neurology.

Multiple sclerosis intra-blood-brain-barrier IgG synthesis: effect of pulse intravenous and intrathecal corticosteroids

K. Syndulko, W. Tourtellotte, P. Shapshak, 1989, The Italian Journal of Neurological Sciences.

Primary memory in patients with frontal and primary generalized epilepsy

Eric Halgren, E. Halgren, B. Swartz, 1994 .

D2 dopamine receptor TaqI A alleles in medically ill alcoholic and nonalcoholic patients.

K. Syndulko, E. Noble, T. Ritchie, 1994, Alcohol and alcoholism.

Selecting Neurologic Function Tests for Parkinson’s Disease: A Primer

K. Syndulko, W. Tourtellotte, G. Kondraske, 1995 .

The long march of the cerebrospinal fluid profile indicative of clinical definite multiple sclerosis; and still marching

S. Engelmann, K. Syndulko, G. Ellison, 1988, Journal of Neuroimmunology.

Multiple Sclerosis De Novo Central Nervous System IgG Synthesis: Measurement, Antibody Profile, Significance, Eradication, and Problems

K. Syndulko, W. Tourtellotte, A. Potvin, 1980 .

Reply to — Bromocriptine in the treatment of alcoholics

K. Syndulko, E. Noble, B. Lawford, 1995, Nature Medicine.

Applications of Human Performance Measurements to Clinical Trials to Determine Therapy Effectiveness and Safety

K. Syndulko, P. Beehler, 1999 .

The basis of intra‐blood‐brain‐barrier IgG synthesis

S. Staugaitis, K. Syndulko, W. Tourtellotte, 1985, Annals of neurology.

Critical frequency of photic driving in the diagnosis of multiple sclerosis. A comparison to pattern evoked responses.

K. Syndulko, W. Tourtellotte, A. Potvin, 1980, Archives of neurology.

Variability on serial testing of visual evoked potentials in patients with multiple sclerosis.

K. Syndulko, W. Tourtellotte, A. Potvin, 1982, Advances in neurology.

Critical frequency of photic driving in the diagnosis of multiple sclerosis.

K. Syndulko, W. Tourtellotte, S. Cohen, 1986, Archives of neurology.

Visual evoked potentials and long latency event‐related potentials in chronic renal failure

K. Syndulko, W. Tourtellotte, J. Kraut, 1983, Neurology.

A placebo‐controlled, randomized, double‐masked, variable dosage, clinical trial of azathioprine with and without methylprednisolone in multiple sclerosis

M. R. Mickey, K. Syndulko, G. Ellison, 1989, Neurology.

Cerebrospinal fluid (CSF) analyses in HIV-1 primary neurological disease

K. Syndulko, W. Tourtellotte, J. Nogales-Gaete, 1992, The Italian Journal of Neurological Sciences.

D2 dopamine receptor gene and obesity.

D. Grandy, K. Syndulko, E. Noble, 1994, The International journal of eating disorders.

Multiple sclerosis

J. Fleming, K. Syndulko, W. Tourtellotte, 1980, Neurology.

Effects of Temperature in Multiple Sclerosis: A Review of the Literature

K. Syndulko, W. Tourtellotte, M. Jafari, 1996 .

Cognitive Function in Old and Very Old Residents of a Residential Facility: Relationship to Age, Education, and Dementia

K. Syndulko, D. Osterweil, Patty Mulford, 1994, Journal of the American Geriatrics Society.

Endogenous event-related potentials: prospective applications in neuropsychology and behavioral neurology.

K. Syndulko, W. Tourtellotte, A. Potvin, 1982, Bulletin of the Los Angeles neurological societies.

Techniques in PCR and PCR Evaluation Technology and Its Application to the Study of Cerebrospinal Fluid in HIV Disease

E. Singer, K. Syndulko, W. Tourtellotte, 1995 .

Cognitive Function in Non‐Demented Older Adults with Hypothyroidism

Stanley N Cohen, J. Cummings, K. Syndulko, 1992, Journal of the American Geriatrics Society.

Cognition in Parkinson disease: An event‐related potential perspective

K. Syndulko, W. Tourtellotte, A. Potvin, 1982, Annals of neurology.

Alcohol and alcoholism.

K. Blum, P. Anderson, K. Syndulko, 1981, British medical journal.

J. Rohrbaugh, D. Lindsley, T. Sanquist, 1980, Progress in brain research.

D2 dopamine receptor gene and cigarette smoking: a reward gene?

S. S. St. Jeor, K. Syndulko, E. Noble, 1994, Medical hypotheses.

Psychophysiology of sociopathy: Electrocortical measures

K. Syndulko, I. Maltzman, E. Ziskind, 1975, Biological Psychology.

A Computer-Based System for Automated Quantitation of Neurologic Function

George V. Kondraske, Alfred R. Potvin, Wallace W. Tourtellotte, 1984, IEEE Transactions on Biomedical Engineering.

Trans-blood-brain-barrier albumin leakage and comparisons of intrathecal IgG synthesis calculations in multiple sclerosis patients

K. Syndulko, W. Tourtellotte, A. Conrad, 1993, Journal of Neuroimmunology.

Comparative evaluations of neuroperformance and clinical outcome assessments in chronic progressive multiple sclerosis: I. reliability, validity and sensitivity to disease progression

K. Syndulko, G. Ellison, W. Tourtellotte, 1996, Multiple sclerosis.

Recommendations from the national multiple sclerosis society clinical outcomes assessment task force

Christian Confavreux, John Petkau, Karl Syndulko, 1997, Annals of neurology.

Clinical outcomes assessment in multiple sclerosis

Christian Confavreux, Alan Thompson, Stephen M. Rao, 1996, Annals of neurology.

Cortical slow negative waves following non-paired stimuli: effects of task factors.

J. Rohrbaugh, D. Lindsley, K. Syndulko, 1978, Electroencephalography and clinical neurophysiology.

15 – INTRA-BLOOD-BRAIN-BARRIER IgG SYNTHESIS IN HIV1

E. Singer, K. Syndulko, W. Tourtellotte, 1989 .

Association of the D2 dopamine receptor A1 allele with alcoholism: Medical severity of alcoholism and type of controls

R. Young, K. Syndulko, E. Noble, 1997, Biological Psychiatry.

HIV penetration of the BBB

L. Resnick, K. Syndulko, W. Tourtellotte, 1988, Neurology.

Multiple Sclerosis Clinical Trials: A Comprehensive System for the Measurement and Evaluation of Neurologic Function

K. Syndulko, W. Tourtellotte, A. Potvin, 1980 .

Design strategies in multiple sclerosis clinical trials

K. Syndulko, G. Ellison, W. Tourtellotte, 1994 .

Long-latency event-related potentials in normal aging and dementia.

K. Syndulko, W. Tourtellotte, A. Potvin, 1982, Advances in neurology.

Decreased verbal memory associated with anticholinergic treatment in Parkinson's disease patients.

K. Syndulko, W. Tourtellotte, A. Potvin, 1981, The International journal of neuroscience.

Brain wave components of the contingent negative variation in humans.

D B Lindsley, J W Rohrbaugh, J. Rohrbaugh, 1976, Science.

Intrathecal IgG synthesis and albumin leakage are increased in subjects with HIV-1 neurologic disease.

E. Singer, K. Syndulko, W. Tourtellotte, 1994, Journal of acquired immune deficiency syndromes.

Effect of anticholinergics on memory in Parkinson's disease.

K. Syndulko, W. Tourtellotte, 1983, Archives of neurology.

Painful symptoms reported by ambulatory HIV-infected men in a longitudinal study

E. Singer, K. Syndulko, W. Tourtellotte, 1993, Pain.

A commentary on correlates between cerebrospinal fluid gamma-globulins and magnetic resonance imaging in multiple sclerosis.

K. Syndulko, W. Tourtellotte, R. Baumhefner, 1990, Archives of neurology.

Size of multiple sclerosis (MS) plaque volume in cerebrum correlates directly with intra-BBB IgG synthesis rate in vivo

K. Syndulko, G. Ellison, W. Tourtellotte, 1988, Journal of Neuroimmunology.

Quantitative Examination Of Neurologic Functions

K. Syndulko, W. Tourtellotte, G. Kondraske, 1985 .

Human neuro-specimen banking 1961-1992. The National Neurological Research Specimen Bank (a donor program of pre- and post-mortem tissues and cerebrospinal fluid/blood; and a collection of cryopreserved human neurological specimens for neuroscientists).

K. Syndulko, W. Tourtellotte, A. Conrad, 1993, Journal of neural transmission. Supplementum.

Quantitative methods in assessment of neurologic function.

J Potvin, K. Syndulko, W. Tourtellotte, 1981, Critical reviews in bioengineering.

Cortical slow negative waves following non-paired stimuli: effects of modality, intensity and rate of stimulation.

D B Lindsley, J W Rohrbaugh, J. Rohrbaugh, 1979, Electroencephalography and clinical neurophysiology.

Synthesis of the contingent negative variation brain potential from noncontingent stimulus and motor elements.

D B Lindsley, T F Sanquist, J W Rohrbaugh, 1980, Science.

Neopterin and β2‐microglobulin and the assessment of intra‐blood‐brain‐barrier synthesis of hiv‐specific and total igg

E. Singer, K. Syndulko, W. Tourtellotte, 1991 .

Cerebrospinal fluid p24 antigen levels and intrathecal immunoglobulin G synthesis are associated with cognitive disease severity in HIV‐1

L. Resnick, E. Singer, K. Syndulko, 1994, AIDS.

Quantifying HIV-1 proviral DNA using the polymerase chain reaction on cerebrospinal fluid and blood of seropositive individuals with and without neurologic abnormalities.

E. Singer, K. Syndulko, W. Tourtellotte, 1994, Journal of acquired immune deficiency syndromes.

ASSESSMENT OF DISABILITY IN MULTIPLE SCLEROSIS BY A TRAINED TECHNICIAN

K. Syndulko, W. Tourtellotte, A. Potvin, 1981 .

A comprehensive protocol for clinical trials in multiple sclerosis which favored azathioprine and corticosteroid as a type of treatment for the chronic progressive phase

K. Syndulko, W. Tourtellotte, P. Shapshak, 1988, Neurology.

Age Differences in Cortical Activity Associated with Preparation to Respond

K. Syndulko, Joyce Parr Schaie, 1978 .

Autonomic activity during anticipation of an aversive tone in noninstitutionalized sociopaths.

K. Syndulko, I. Maltzman, E. Ziskind, 1980, Psychophysiology.

Neuroperformance Evaluation of Multiple Sclerosis Disease Progression in a Clinical Trial: Implications for Neurological Outcomes

K. Syndulko, G. Ellison, W. Tourtellotte, 1993 .

Carbidopa-Levodopa Ratio in Parkinson's Disease

K. Syndulko, W. Tourtellotte, A. Potvin, 1981 .